• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-06-18

  This study demonstrates that pharmacological SMYD2 inhibition, including with LLY-507, protects against cisplatin-induced renal fibrosis and inflammation in chronic kidney disease models. The findings establish SMYD2 as a mechanistically relevant epigenetic regulator in renal injury and suggest new directions for antifibrotic kidney disease research.

• Tolazoline: Translational Leverage in α2-Adrenergic Signalin

  2026-06-18

  This thought-leadership article explores Tolazoline’s mechanistic action as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker, providing translational researchers with evidence-driven insights into protocol design, assay optimization, and cross-disease pathway exploration. Drawing on recent advances in insulin signaling disruption in neurodegenerative disease, the article situates APExBIO’s Tolazoline at the forefront of metabolic, neuroendocrine, and airway smooth muscle research, while addressing both competitive context and future outlook.

• Annexin V-Cy5 Apoptosis Kit: Decoding Microglial Apoptosis a

  2026-06-17

  Explore how the Annexin V-Cy5 Apoptosis Kit enables precise apoptosis detection in microglia, with unique insights into lysosomal dysfunction and neuroimmune research applications. This article offers advanced guidance for researchers seeking to bridge apoptosis analysis with lysosomal stress models.

• HSP90 Inhibition Destabilizes METTL3 and Alters MYC m6A in C

  2026-06-17

  This study elucidates a novel HSP90-METTL3 regulatory axis in colorectal cancer, showing that pharmacological inhibition of HSP90 by 17-AAG destabilizes the methyltransferase METTL3, reducing MYC mRNA m6A modification and suppressing oncogenic phenotypes. The findings highlight mechanistic insights and potential therapeutic targets for RNA modification-driven cancers.

• Hoechst 33342 Nuclear Stain: Optimizing Live Cell Workflows

  2026-06-16

  Hoechst 33342 Solution (1 mg/mL) from APExBIO stands out for robust, low-toxicity nuclear staining in both live and fixed cells, enabling advanced imaging and cytometry workflows. This guide translates leading-edge dermal senescence research into actionable protocols, troubleshooting tips, and comparative advantages for high-content applications.

• Nuclear cGAS Restricts L1 Retrotransposition via TRIM41-Medi

  2026-06-16

  This study uncovers a key role for nuclear cGAS in safeguarding genome integrity by repressing LINE-1 (L1) retrotransposition. The findings reveal a CHK2-cGAS-TRIM41-ORF2p axis that promotes degradation of L1-encoded ORF2p, with implications for aging and cancer biology.

• Combinatorial Targeting of eIF4F, AKT1, and EZH2 in BRAFV600

  2026-06-15

  This study demonstrates that simultaneous inhibition of the eIF4F translation initiation complex, AKT1, and EZH2 can overcome resistance to targeted therapies in BRAFV600E mutant melanoma cells. The findings suggest that combining these molecular interventions enhances anticancer effects and provides a rationale for multi-targeted therapeutic strategies in melanoma.

• Ribociclib Succinate (LEE011): Integrative Insights in CDK I

  2026-06-15

  Explore the scientific mechanisms and advanced applications of Ribociclib succinate (LEE011 succinate) as a selective CDK inhibitor in cancer research. This article delivers a unique perspective on solubility, assay design, and translational relevance, distinguishing itself from existing resources.

• Sildenafil Citrate: Advanced Protocols for Vascular Biology

  2026-06-14

  Sildenafil Citrate, a potent cGMP-specific phosphodiesterase type 5 inhibitor, is transforming vascular biology and proteoform-targeted research. This article offers actionable workflows, troubleshooting strategies, and evidence-backed protocol refinements to maximize discovery in signal transduction and vascular smooth muscle relaxation studies.

• Large-Scale Gastruloid Arrays Reveal Early Developmental Def

  2026-06-13

  This study introduces a high-throughput microraft array platform for large-scale imaging, sorting, and molecular analysis of 2D human gastruloids, enabling the detection of subtle phenotypic and gene expression differences between euploid and aneuploid models. The approach advances the field by allowing systematic screening of developmental abnormalities at single-gastruloid resolution.

• 3-Deazaneplanocin (DZNep): Protocols and Innovations in Epig

  2026-06-12

  3-Deazaneplanocin (DZNep) empowers researchers to dissect epigenetic pathways and target cancer stem cells with precision. This guide delivers actionable workflows, troubleshooting strategies, and key insights from the latest translational research, setting a new benchmark for experimental rigor in oncology and metabolic disease modeling.

• Structural Mechanisms of PSS2 and Regulation of SREBP Pathwa

  2026-06-12

  This study elucidates the structural and functional divergence between human phosphatidylserine synthase 2 (PSS2) and its homolog PSS1, revealing substrate specificity and distinct roles in SREBP pathway regulation. The findings have important implications for understanding lipid metabolism and designing mechanistic studies on phospholipid-related cellular signaling.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Next-Gen Cytokine Modulation

  2026-06-11

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers advanced cytokine modulation for immunotherapy research. This article uniquely dissects mRNA engineering, delivery, and translational strategies, revealing new insights for gene expression studies.

• Adiponectin Mitigates Neuroinflammation After Splenectomy in

  2026-06-11

  This study demonstrates that adiponectin alleviates cognitive deficits following splenectomy in aged rats by suppressing the TLR4/MyD88/NF-κB pathway, thereby reducing neuroinflammation and oxidative stress. The results clarify mechanistic links in perioperative neurocognitive disorder and suggest practical strategies for targeting inflammation in elderly surgical patients.

• Oseltamivir Acid: Advanced Influenza Neuraminidase Inhibitor

  2026-06-10

  Oseltamivir acid transcends its origins as an influenza neuraminidase inhibitor, offering validated workflows for both antiviral and cancer metastasis research. This article unpacks stepwise protocols, advanced applications, and troubleshooting strategies to maximize reproducibility and impact.

16417 records 1/1095 page Next 12345 下5页 Last page